BackIsracann Biosciences Overview

Isracann Biosciences Current Assets

Isracann Biosciences's current assets is $300K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$304131.00
↓ 81.70% YoYΔ $-1.36M vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Current Assets History

Loading

Isracann Biosciences vs. peers: Current Assets Comparison

Loading

Isracann Biosciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Isracann Biosciences (IPOT.CN) FAQ

Isracann Biosciences posts a current assets of $300K as of August 2022. That compares with $1.7M in the prior-year period — down 81.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Isracann Biosciences's current assets was $1.7M. The latest reading is $300K — a 81.7% year-over-year decrease (period ending August 2022). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Isracann Biosciences's financial statement story. At $300K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for IPOT.CN's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Isracann Biosciences's other metric pages and overview cover the third.